Analysis of Ivacaftor drug approval for cystic fibrosis patients with gating mutations.
Cystic fibrosis is an inherited monogenetic disorder that leads to chronic respiratory and lung infections. These infections result in decreased quality of life in patients. Quality of life (QOL) can be attributed to many disease characteristics such as hospitalization, organ transplant, depression,...
Wedi'i Gadw mewn:
| Prif Awdur: | |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Royal St. George's College
2021-08-01
|
| Cyfres: | The Young Researcher |
| Pynciau: | |
| Mynediad Ar-lein: | http://www.theyoungresearcher.com/papers/nemirajaiah.pdf |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|